Pediatric Endocrine Society (PES 2026) 30 April - 3 May 2026

Once-weekly somapacitan in children with turner syndrome (REAL8): a randomised, phase 3 Trial

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Rare Endocrine Disorder
Congress oral presentation
Somapacitan